Related Experiment Video

Updated: Aug 20, 2026

Hickman Catheter Use for Long-Term Vascular Access in a Preclinical Swine Model
08:51

Hickman Catheter Use for Long-Term Vascular Access in a Preclinical Swine Model

Published on: March 31, 2023

[Outcome of tunneled hemodialysis catheters as permanent vascular access]

J Hernández-Jaras1, H García-Pérez, E Torregrosa

  • 1Servicio de Nefrología, Hospital General de Castellón, Centro de Diálisis Gambro HealthCare. hernandez_jul@gva.es

Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|January 15, 2005
PubMed

Insights

Tunneled cuffed hemodialysis catheters (THC) offer a viable long-term vascular access option for hemodialysis patients. Despite some procedural complications, THC demonstrated acceptable survival rates and effectiveness when other access methods are not feasible.

Area of Science:

  • Nephrology
  • Vascular Surgery
  • Medical Devices

Background:

  • Tunneled cuffed hemodialysis catheters (THC) provide temporary vascular access for hemodialysis.
  • They are used while more permanent access matures or when other options are unavailable.

Purpose of the Study:

  • To evaluate the effectiveness, survival rates, and complications of THC for long-term hemodialysis access.

Main Methods:

  • A retrospective study analyzed 42 THC insertions in 40 elderly patients between November 2000 and October 2003.
  • Patients had systemic disease or lacked other vascular access options.

Main Results:

  • Procedural complications occurred in 11.9% of cases, including hemorrhage and a fatal venous tear.
  • Catheter survival at one, three, and twelve months was 90.4%, 73.1%, and 59.5%, respectively.
  • Infections occurred at a rate of 0.18 episodes per 1,000 catheter-days.

Conclusions:

  • THC can serve as a useful alternative permanent vascular access for hemodialysis patients.
  • Effectiveness and survival rates support THC use when other vascular access options are not possible.
Abstract

More Related Videos

A Murine Model of Hemodialysis Access-Related Hand Dysfunction08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...